“We've still only got about 300 sequences of the variant in South Africa. “That could potentially indicate that even if the vaccines work against the variants we have now, there is a chance that they may not work against further mutations. Scientists are currently investigating how all the new variants will impact the protection offered by vaccines. The KRISP team is conducting research looking at how antibodies work against the 501Y.V2 variant in South Africa in a lab setting. What's really needed now is more vaccines being approved, more vaccines being deployed, and we need the vaccine rollout to go faster.

Source: News 24 January 15, 2021 04:07 UTC